Extensive methylation of hMLH1 promoter region predominates in proximal colon cancer with microsatellite instability - PubMed (original) (raw)
Extensive methylation of hMLH1 promoter region predominates in proximal colon cancer with microsatellite instability
Y Miyakura et al. Gastroenterology. 2001 Dec.
Abstract
Background & aims: Methylation of the hMLH1 promoter region has been suggested to cause microsatellite instability (MSI) in sporadic colorectal carcinoma (CRC). We studied the methylation profile in a wide region of the hMLH1 promoter and compared with the hMLH1 protein expression and MSI status in 88 cases of sporadic CRC.
Methods: Na-bisulfite treatment and polymerase chain reaction single-strand conformation polymorphism analysis was performed using 5 sets of polymerase chain reaction primers spanning the promoter region of the hMLH1 to examine methylation status. Results were compared with immunostaining using anti-hMLH1 monoclonal antibody and MSI status of the tumor samples.
Results: Methylation status was classified as full or partial methylation. Full methylation indicates the methylation of all CpG sites in the examined regions. Methylation of the hMLH1 promoter was observed in 88.9% (16 of 18) of CRCs showing high frequency MSI (MSI-H), among which 89% (14 of 16) had full methylation with reduced hMLH1 protein expression. All cases showing full methylation were proximal colon tumors with MSI-H. In cases with partial methylation, only the upstream region of the hMLH1 promoter was methylated. Partial methylation was also shown in 33.3% (6 of 18) of the normal mucosa of MSI-H cases. Frequencies of methylation were significantly correlated with female gender (P = 0.0009) and aging (P = 0.007).
Conclusions: Full methylation of the hMLH1 promoter region and subsequent gene inactivation may play a crucial role in the carcinogenesis of MSI-H CRCs in the proximal colon. Methylation upstream of the hMLH1 promoter appears to be an early event in the carcinogenesis of MSI-H tumors.
Comment in
- Multistep progression of colorectal cancer in the setting of microsatellite instability: new details and novel insights.
Goel A, Arnold CN, Boland CR. Goel A, et al. Gastroenterology. 2001 Dec;121(6):1497-502. doi: 10.1053/gast.2001.29978. Gastroenterology. 2001. PMID: 11729129 Review. No abstract available.
Similar articles
- Extensive but hemiallelic methylation of the hMLH1 promoter region in early-onset sporadic colon cancers with microsatellite instability.
Miyakura Y, Sugano K, Akasu T, Yoshida T, Maekawa M, Saitoh S, Sasaki H, Nomizu T, Konishi F, Fujita S, Moriya Y, Nagai H. Miyakura Y, et al. Clin Gastroenterol Hepatol. 2004 Feb;2(2):147-56. doi: 10.1016/s1542-3565(03)00314-8. Clin Gastroenterol Hepatol. 2004. PMID: 15017620 - Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.
Cunningham JM, Christensen ER, Tester DJ, Kim CY, Roche PC, Burgart LJ, Thibodeau SN. Cunningham JM, et al. Cancer Res. 1998 Aug 1;58(15):3455-60. Cancer Res. 1998. PMID: 9699680 - The profile of hMLH1 methylation and microsatellite instability in colorectal and non-small cell lung cancer.
Okuda T, Kawakami K, Ishiguro K, Oda M, Omura K, Watanabe G. Okuda T, et al. Int J Mol Med. 2005 Jan;15(1):85-90. Int J Mol Med. 2005. PMID: 15583832 - Evaluation of microsatellite instability, hMLH1 expression and hMLH1 promoter hypermethylation in defining the MSI phenotype of colorectal cancer.
Arnold CN, Goel A, Compton C, Marcus V, Niedzwiecki D, Dowell JM, Wasserman L, Inoue T, Mayer RJ, Bertagnolli MM, Boland CR. Arnold CN, et al. Cancer Biol Ther. 2004 Jan;3(1):73-8. doi: 10.4161/cbt.3.1.590. Epub 2004 Jan 5. Cancer Biol Ther. 2004. PMID: 14726676 - Profile of methylated CpG sites of hMLH1 promoter in primary gastric carcinoma with microsatellite instability.
Kang GH, Lee S, Shim YH, Kim JC, Ro JY. Kang GH, et al. Pathol Int. 2002 Dec;52(12):764-8. doi: 10.1046/j.1440-1827.2002.01423.x. Pathol Int. 2002. PMID: 12588445
Cited by
- Oncological characteristics, treatments and prognostic outcomes in MMR-deficient colorectal cancer.
Fan WX, Su F, Zhang Y, Zhang XL, Du YY, Gao YJ, Li WL, Hu WQ, Zhao J. Fan WX, et al. Biomark Res. 2024 Aug 26;12(1):89. doi: 10.1186/s40364-024-00640-7. Biomark Res. 2024. PMID: 39183366 Free PMC article. Review. - Testing region selection and prognostic analysis of MLH1 promoter methylation in colorectal cancer in China.
Tan X, Fang Y, Fan X, Deng W, Huang J, Cai Y, Zou J, Chen Z, Lin H, Xu L, Wang G, Zhan H, Huang S, Fu X. Tan X, et al. Gastroenterol Rep (Oxf). 2024 Apr 2;12:goae011. doi: 10.1093/gastro/goae011. eCollection 2024. Gastroenterol Rep (Oxf). 2024. PMID: 38566849 Free PMC article. - Diagnosis of patients with Lynch syndrome lacking the Amsterdam II or Bethesda criteria.
Trujillo-Rojas MA, Ayala-Madrigal ML, Gutiérrez-Angulo M, González-Mercado A, Moreno-Ortiz JM. Trujillo-Rojas MA, et al. Hered Cancer Clin Pract. 2023 Oct 20;21(1):21. doi: 10.1186/s13053-023-00266-0. Hered Cancer Clin Pract. 2023. PMID: 37864171 Free PMC article. Review. - Detection of Microsatellite Instability in Colorectal Cancer Patients With a Plasma-Based Real-Time PCR Analysis.
Kim N, Kim SM, Lee BJ, Choi BI, Yoon HS, Kang SH, Kim SH, Joo MK, Park JJ, Kim C. Kim N, et al. Front Pharmacol. 2021 Dec 8;12:758830. doi: 10.3389/fphar.2021.758830. eCollection 2021. Front Pharmacol. 2021. PMID: 34955830 Free PMC article. - Clinical and epigenetic features of colorectal cancer patients with somatic POLE proofreading mutations.
Kawai T, Nyuya A, Mori Y, Tanaka T, Tanioka H, Yasui K, Toshima T, Taniguchi F, Shigeyasu K, Umeda Y, Fujiwara T, Okawaki M, Yamaguchi Y, Goel A, Nagasaka T. Kawai T, et al. Clin Epigenetics. 2021 May 25;13(1):117. doi: 10.1186/s13148-021-01104-7. Clin Epigenetics. 2021. PMID: 34034807 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources